• For the symptomatic treatment of mental losses due to organic brain syndrome within the framework of a general therapeutic concept for dementia syndromes having as major symptoms: Deficient memory, disturbances of concentration, depressive mood, dizziness, tinnitus and headache.The primary target group includes patients with demential syndrome in primary degenerative dementia, vascular dementia and mixed forms of both.• Vertigo of vascular and involutional origin.• Adjuvant treatment in case of tinnitus of vascular and involutional origin.